Yong-Hao Yeo
Overview
Explore the profile of Yong-Hao Yeo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
2
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yeo Y, Lim G, Mee X, Ang Q, Tan M
Cardiovasc Revasc Med
. 2025 Feb;
PMID: 39919980
Background: There is an increasing preference of utilizing valve-in-valve transcatheter aortic valve replacement (ViV TAVR) after bioprosthetic valve failure. However, updated large-scale analysis investigating early-mortality after the patients underwent ViV...
2.
Yeo Y, San B, Tan J, Tan M, Donisan T, Lee J, et al.
Cardiooncology
. 2024 Dec;
10(1):89.
PMID: 39696722
Background: Breast cancer survivors face a higher risk of cardiovascular disease (CVD) compared to non-breast cancer patients, yet contemporary data on CVD-related mortality within this group remains scarce. Objective: To...
3.
Yeo Y, San B, Ahmad E, Tan M, Sin Y, Jani M, et al.
Prev Med
. 2024 Nov;
190:108179.
PMID: 39561854
Objective: Our study aimed to assess the heart failure/cardiomyopathy-related population-level mortality trends among patients with obesity in the United States and disparities across demographics. Methods: We queried the Centers for...
4.
Tan J, San B, Yeo Y, Chan K, Shaaban H, Ezekwudo D, et al.
JAMA Netw Open
. 2024 Sep;
7(9):e2440599.
PMID: 39348116
Importance: Social determinants of health (SDOH) influence health outcomes, including those of sickle cell disease (SCD), despite advancements in treatments like disease-modifying therapies. Objective: To investigate the association of SDOH...
5.
Yeo Y, San B, Mee X, Tan M, Abbas A, Shanmugasundaram M, et al.
Am J Med
. 2024 Sep;
138(1):51-60.e2.
PMID: 39284481
Background: Real-world mortality data regarding heart failure in patients with comorbid chronic kidney disease remains limited, especially following the advent of advanced heart failure therapies. Methods: Using the CDC WONDER...
6.
Risk factors for early mortality following transcatheter edge-to-edge repair of mitral regurgitation
Yeo Y, Thong J, Tan M, Ang Q, San B, Tan B, et al.
Cardiovasc Revasc Med
. 2024 Aug;
PMID: 39168760
Background: While transcatheter edge-to-edge repair (TEER) with MitraClip is increasingly used, data on the risk stratification for assessing early mortality after this procedure are scarce. Objective: This study aimed to...
7.
Yeo Y, San B, Ang Q, Tan M, Tan J
J Arrhythm
. 2024 Aug;
40(4):1001-1004.
PMID: 39139881
Background: The impact of atrial fibrillation (AF) among patients with amyloidosis on in-hospital outcomes is not well-established. We aimed to examine in-hospital outcomes among patients admitted with a primary diagnosis...
8.
Yeo Y, Tan M, Ang Q, Tan J, Lee J, Mehta N
JACC Clin Electrophysiol
. 2024 Jun;
10(6):1203-1205.
PMID: 38925722
No abstract available.
9.
Tan J, Yeo Y, Ng W, Fong Z, Brady J
Int J Cancer
. 2024 Mar;
155(3):493-500.
PMID: 38525799
In the last two decades, colorectal cancer (CRC) mortality has been decreasing in the United States. However, the mortality trends for the different subtypes of CRC, including different sides of...
10.
Tan J, Yeo Y, Tan M, Chavez J, Chisti M
Br J Haematol
. 2023 Dec;
204(3):1114-1117.
PMID: 38155366
No abstract available.